Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1. subject is ≥18 years of age. 2. male or female. females of childbearing (reproductive) potential must have a negative urine pregnancy test at screening. 3. subject with diagnosis of covid-19 based on + rna or immunoglobulin m (igm) test or compatible clinical presentation\* who: 1. is being discharged from the emergency department without hospitalization, or 2. is admitted to the hospital or was previously hospitalized and still in the hospital, does not require invasive mechanical ventilation and does not require management in the intensive care unit. inpatients can be enrolled in the study at any time of their hospitalization, if they comply with the inclusion criteria. (\*)compatible clinical presentation will consider compatible symptoms (cough, fever, myalgia, dyspnea, ageusia / anosmia) and examination of general condition, heart rate and respiratory rate, oxygen saturation, cardiopulmonary auscultation, compatible radiology. 4. ability to consume enteragam. 5. subject or surrogate decision maker is capable of understanding the requirements of the study, understands the language of the informed consent form, and is capable and willing to sign the informed consent form.

inclusion criteria: 1. subject is ≥18 years of age. 2. male or female. females of childbearing (reproductive) potential must have a negative urine pregnancy test at screening. 3. subject with diagnosis of covid-19 based on + rna or immunoglobulin m (igm) test or compatible clinical presentation\* who: 1. is being discharged from the emergency department without hospitalization, or 2. is admitted to the hospital or was previously hospitalized and still in the hospital, does not require invasive mechanical ventilation and does not require management in the intensive care unit. inpatients can be enrolled in the study at any time of their hospitalization, if they comply with the inclusion criteria. (\*)compatible clinical presentation will consider compatible symptoms (cough, fever, myalgia, dyspnea, ageusia / anosmia) and examination of general condition, heart rate and respiratory rate, oxygen saturation, cardiopulmonary auscultation, compatible radiology. 4. ability to consume enteragam. 5. subject or surrogate decision maker is capable of understanding the requirements of the study, understands the language of the informed consent form, and is capable and willing to sign the informed consent form.

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: subject is ≥18 years of age. male or female. females of childbearing (reproductive) potential must have a negative urine pregnancy test at screening. subject with diagnosis of covid-19 based on + rna or immunoglobulin m (igm) test or compatible clinical presentation* who: is being discharged from the emergency department without hospitalization, or is admitted to the hospital or was previously hospitalized and still in the hospital, does not require invasive mechanical ventilation and does not require management in the intensive care unit. inpatients can be enrolled in the study at any time of their hospitalization, if they comply with the inclusion criteria. (*)compatible clinical presentation will consider compatible symptoms (cough, fever, myalgia, dyspnea, ageusia / anosmia) and examination of general condition, heart rate and respiratory rate, oxygen saturation, cardiopulmonary auscultation, compatible radiology. ability to consume enteragam. subject or surrogate decision maker is capable of understanding the requirements of the study, understands the language of the informed consent form, and is capable and willing to sign the informed consent form.

inclusion criteria: subject is ≥18 years of age. male or female. females of childbearing (reproductive) potential must have a negative urine pregnancy test at screening. subject with diagnosis of covid-19 based on + rna or immunoglobulin m (igm) test or compatible clinical presentation* who: is being discharged from the emergency department without hospitalization, or is admitted to the hospital or was previously hospitalized and still in the hospital, does not require invasive mechanical ventilation and does not require management in the intensive care unit. inpatients can be enrolled in the study at any time of their hospitalization, if they comply with the inclusion criteria. (*)compatible clinical presentation will consider compatible symptoms (cough, fever, myalgia, dyspnea, ageusia / anosmia) and examination of general condition, heart rate and respiratory rate, oxygen saturation, cardiopulmonary auscultation, compatible radiology. ability to consume enteragam. subject or surrogate decision maker is capable of understanding the requirements of the study, understands the language of the informed consent form, and is capable and willing to sign the informed consent form.

Dec. 25, 2020, 12:31 a.m. usa

inclusion criteria: 1. subject is ≥18 years of age. 2. male or female. females of childbearing (reproductive) potential must have a negative urine pregnancy test at screening. 3. subject with diagnosis of covid-19 based on + rna or immunoglobulin m (igm) test or compatible clinical presentation* who: 1. is being discharged from the emergency department without hospitalization, or 2. is admitted to the hospital or was previously hospitalized and still in the hospital, does not require invasive mechanical ventilation and does not require management in the intensive care unit. inpatients can be enrolled in the study at any time of their hospitalization, if they comply with the inclusion criteria. (*)compatible clinical presentation will consider compatible symptoms (cough, fever, myalgia, dyspnea, ageusia / anosmia) and examination of general condition, heart rate and respiratory rate, oxygen saturation, cardiopulmonary auscultation, compatible radiology. 4. ability to consume enteragam. 5. subject or surrogate decision maker is capable of understanding the requirements of the study, understands the language of the informed consent form, and is capable and willing to sign the informed consent form.

inclusion criteria: 1. subject is ≥18 years of age. 2. male or female. females of childbearing (reproductive) potential must have a negative urine pregnancy test at screening. 3. subject with diagnosis of covid-19 based on + rna or immunoglobulin m (igm) test or compatible clinical presentation* who: 1. is being discharged from the emergency department without hospitalization, or 2. is admitted to the hospital or was previously hospitalized and still in the hospital, does not require invasive mechanical ventilation and does not require management in the intensive care unit. inpatients can be enrolled in the study at any time of their hospitalization, if they comply with the inclusion criteria. (*)compatible clinical presentation will consider compatible symptoms (cough, fever, myalgia, dyspnea, ageusia / anosmia) and examination of general condition, heart rate and respiratory rate, oxygen saturation, cardiopulmonary auscultation, compatible radiology. 4. ability to consume enteragam. 5. subject or surrogate decision maker is capable of understanding the requirements of the study, understands the language of the informed consent form, and is capable and willing to sign the informed consent form.